Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,700
Employees4,700
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,700
Employees4,700

PEN Key Statistics

Market cap
12.85B
Market cap12.85B
Price-Earnings ratio
72.58
Price-Earnings ratio72.58
Dividend yield
Dividend yield
Average volume
630.52K
Average volume630.52K
High today
$328.70
High today$328.70
Low today
$327.16
Low today$327.16
Open price
$328.25
Open price$328.25
Volume
99.30K
Volume99.30K
52 Week high
$362.41
52 Week high$362.41
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

Penumbra(PEN) stock is priced at $327.42, giving the company a market capitalization of 12.85B. It carries a P/E multiple of 72.58.

On 2026-03-31, Penumbra(PEN) stock traded between a low of $327.16 and a high of $328.70. Shares are currently priced at $327.42, which is +0.1% above the low and -0.4% below the high.

The Penumbra(PEN)'s current trading volume is 99.3K, compared to an average daily volume of 630.52K.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

PEN News

TipRanks 22h
FTC issued Second Request to Penumbra, Boston Scientific over merger review

According to a regulatory filing, Penumbra (PEN) and Boston Scientific (BSX) each filed a notification and report form under the HSR Act with the DOJ and the FT...

Simply Wall St 4d
A Look At Penumbra Valuation After Recent Share Performance And STORM PE Trial Expectations

Advertisement Assessing Penumbra after recent share performance Penumbra (PEN) has drawn attention after a mixed stretch for the stock, with a small move over...

A Look At Penumbra Valuation After Recent Share Performance And STORM PE Trial Expectations

Analyst ratings

78%

of 18 ratings
Buy
16.7%
Hold
77.8%
Sell
5.6%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.